17 May, 2022

Giving birth is a miracle in itself. But in some cases, there are slight chances of complications. One such threat to the mother’s life is Postpartum Haemorrhage (also called PPH)

WHAT IS POSTPARTUM HEMORRHAGE?

When a woman experiences heavy bleeding after giving birth, it is called postpartum hemorrhage. It is a rare but serious condition. The bleeding can happen the next day of delivery and for up to 12 weeks.

According to the University of Rochester Medical Centre, about 1 to 5 in 100 women suffer a postpartum hemorrhage.

Losing blood after giving birth is normal. Women lose about 500 ml of blood during vaginal delivery and around 1,000 ml of blood in a C-section. What makes postpartum hemorrhage a dangerous condition is that the woman loses much more blood than this. Not only this, but it can cause a drop in blood pressure. It can lead to shock and death if not treated on time.

WHEN DOES POSTPARTUM HEMORRHAGE HAPPEN?

After the baby is born, the placenta is pushed out as the uterus contracts. This contraction puts pressure on the blood vessels where the placenta is. If these contractions are not strong enough, the blood vessels bleed more. This bleeding can also happen if small pieces of the placenta are left in the uterus.

KEY POINTS:

  • Postpartum hemorrhage happens in 1-5% of females.
  • Call your health provider for emergency care if you think you have postpartum hemorrhage.
  • If you have heavy vaginal blood flow, you may have postpartum hemorrhage that does not slow down or stop.
  • Blurred vision, chills, weakness, and dizziness are all the symptoms you may experience.
  • If you have a history of postpartum hemorrhage or certain medical conditions that affect the uterus, placenta, or blood clots, you’re more likely to suffer from postpartum hemorrhages.

BENEFITS OF SERASEAL™ IN OBSTETRICS GYNAECOLOGY

During childbirth, Caesarean section (CS) surgeries, average blood loss has been observed as 500-1500 ml (1-3 units of blood). The uterus is perfused at 500-750 ml/min, resulting in an average blood loss of approximately 1000 ml (2 units). Vaginal delivery blood loss averages 500 ml; Vaginal delivery with episiotomy and forceps averages 555 ml (11% higher) and Postpartum haemorrhage around 1-5%.

Typically, blood transfusion is required where there is a blood loss of 2 or more units. Therefore, on an average of 70,000 deliveries/day in India and 40% of deliveries being CS, then SeraSeal™ would be able to save 28,000 units of blood/day. This is a considerable cost-saving and a significant risk reduction for the patient. Statistically, approximately 25% of women have a pelvic floor disorder, and 1 in 5 (20%) will have surgery, such as hysterectomy, ovariectomy, dilatation, curettage (D& C), polypectomy, and more.

SeraSeal™ is a primary hemostatic product, and it can be used in place of cauterization or in concert with cauterization, with the following benefits:

  • Effective on all forms of coagulopathy: anticoagulant drugs, platelet inhibitors, factor deficiency.
  • SeraSeal™ can be applied to all tissues, including the bone marrow.
  • Multiple delivery systems: syringe, spray, foam, scope, trochar, catheter, trauma dressing, battlefield dressing, surgical sponges, dental compresses, swabs, and bandage strip.
  • No preparation can be used immediately.
  • Can be used in emergency/trauma cases.
  • Reduces surgical time by as much as 50%.
  • Reduces blood loss by upto 90% in upto 40% surgical procedures.
  • No loss of tissue or adhesions.
  • Promotes healing.
  • Can be used outside of the clinical setting.
  • Can undergo repetitive freeze-thaw cycles without loss of activity.
  • Substantial cost savings through less surgical theatre time, fewer blood transfusions, less anesthesia medication, less pain medication, and shorter ICU and hospital stay.

Brought to India by Swasth Kare, SeraSeal™ is the world’s first and only primary hemostatic agent that stops bleeding in seconds.

Contact us to know more!

17 May, 2022

Add your comment

Your email address will not be published. Required fields are marked *

Subscribe to the newsletter

Receive latest news and updates